期刊文献+

HPLC测定复方莫西沙星滴耳液中的莫西沙星和地塞米松 被引量:4

Determination of moxifloxacin hydrochloride and dexamethasone acetate in Compound moxifloxacin ear drops by HPLC
原文传递
导出
摘要 目的采用HPLC法同时测定复方莫西沙星滴耳液中的盐酸莫西沙星和醋酸地塞米松。方法采用Shim—Pack VP—C18色谱柱(150mm×4.6mm,5μm),柱温30℃,流动相为磷酸盐缓冲液-甲醇(40:60,磷酸调pH3.0);流速为1.0ml·min^-1;检测波长为241nm;进样量20μl。结果盐酸莫西沙星0.3—2.4μg(r=0.9999,n=5)、醋酸地塞米松0.03~0.24μg(r=0.9999,n=5)与峰面积的线性关系良好,平均回收率分别为98.73%(RSD=0.89%)、98.24%(RSD=0.75%)。结论所建方法简便、快速、准确、重复性好,可用于复方莫西沙星滴耳液的质量控制。 OBJECTIVE To establish an HPLC method for determination of moxifloxacin hydrochloride and dexamethasone acetate in Compound moxifloxacin ear drops simultaneously. METHODS The chromatographic column was SHIM - PACK VP - ODS( 150 mm× 4.6 mm,5 μm), with column temperature of 30℃. The mobile phase consisted of phosphate buffer solution( which contained 0.02 mol · L^-1 sodium dihydrogen phosphate and 0.3% triethylamine) - methanol(40 : 60, adjust pH to 3.0 by phosphoric acid), The flow rate was 1.0 ml·min^-1 and the detection wavelength was at 241 nm and the injected volume was 20 μl. RESULTS The calibration curve for moxifloxacin hydrochlofide was linear between 0.3 -2.4μg (r =0, 9999 ,n =5 ) and the average recovery rate was 98.73% with RSD of 0.89%. The calibration curve for dexamethasone acetate was linear between 0.03 - 0.24 μg ( r = 0.9999, n = 5) and the average recovery rate was 98.24% with RSD of 0.75%. CONCLUSION The method is simple, rapid, accurate, reproducible and can be used for quantity control of compound moxifloxacin ear drops.
出处 《华西药学杂志》 CAS CSCD 北大核心 2009年第2期188-189,共2页 West China Journal of Pharmaceutical Sciences
关键词 复方莫西沙星滴耳液 盐酸莫西沙星 醋酸地塞米松 高效液相色谱法 Compound moxifloxacin ear drops Moxifloxacin hydrochloride Dexamethasone acetate HPLC
  • 相关文献

参考文献3

二级参考文献9

  • 1李玮,胡昌勤,杭太俊,田颂九.色谱相关光谱法识别莫西沙星HPLC分析中的有关物质色谱峰[J].中国药学杂志,2006,41(8):627-631. 被引量:15
  • 2[1]Woodcock J M, Andrews J M, Boswell F J. et al. In vitro activity of BAY 12-8039, a new fluoroquinolone [J]. Antimicrob AgentsChemother , 1997;41:1101
  • 3[2]Hoogkamp-Korstanje J A, Roelofs-Winemse J. Comparative invitro activity of moxitloxacin against Gram-positive clinical isolates[J]. J Antimicrob Chemother, 2000; 45 (1): 31
  • 4[3]Sunderland J, Tobin C M, Hedges A J, et al. Antimicrobial activity of fluoroquinolone photodegradation products determinated byparallel-line bioassay and high performance liquid chromatography[J]. JAntimicrob Chemother, 2001; 47 (3): 271
  • 5[4]Stass H, Kubitza D. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administation in man [J]. JAntimicrob Chemother, 1999; 43 (Supple B): 83
  • 6[5]Stass H, Dalhoff A. Determination of BAY12-8039, a new 8methoxyquinolone, in human body fluids by high-performance liqnid chromatography with fluorescence detection using on-columnfocusing [J]. J Chromatogr Biomed Appl, 1997; 702 ( 1 ~ 2):163
  • 7[6]Moller J G, Stass H, Heinig R, et al. Capillary electrophoresiswith laser-induced fluorescence: a routine method to determinemoxifloxacin in human body fluids in very small sample volumes[J]. J Chromatog, 1998; 716:325
  • 8张英,赵志刚,张杰.莫西沙星——一种新的氟喹诺酮类药物[J].中国临床药理学杂志,2002,18(5):396-400. 被引量:45
  • 9蒋锦,刘明亮.莫西沙星在治疗呼吸道感染中的地位[J].国外医药(抗生素分册),2003,24(6):276-279. 被引量:19

共引文献60

同被引文献27

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部